- Home
- FMAO vs CDXS Comparison
FMAO vs CDXS Comparison
Compare FMAO & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMAO
- CDXS
- Stock Information
- Founded
- FMAO 1897
- CDXS 2002
- Country
- FMAO United States
- CDXS United States
- Employees
- FMAO N/A
- CDXS N/A
- Industry
- FMAO Savings Institutions
- CDXS Major Chemicals
- Sector
- FMAO Finance
- CDXS Industrials
- Exchange
- FMAO Nasdaq
- CDXS Nasdaq
- Market Cap
- FMAO 377.5M
- CDXS 332.0M
- IPO Year
- FMAO N/A
- CDXS 2010
- Fundamental
- Price
- FMAO $29.92
- CDXS $5.28
- Analyst Decision
- FMAO Hold
- CDXS Buy
- Analyst Count
- FMAO 2
- CDXS 2
- Target Price
- FMAO $26.00
- CDXS $11.00
- AVG Volume (30 Days)
- FMAO 24.1K
- CDXS 875.4K
- Earning Date
- FMAO 02-11-2025
- CDXS 10-31-2024
- Dividend Yield
- FMAO 2.96%
- CDXS N/A
- EPS Growth
- FMAO N/A
- CDXS N/A
- EPS
- FMAO 1.69
- CDXS N/A
- Revenue
- FMAO $98,003,000.00
- CDXS $64,446,000.00
- Revenue This Year
- FMAO N/A
- CDXS N/A
- Revenue Next Year
- FMAO $8.16
- CDXS $2.02
- P/E Ratio
- FMAO $17.71
- CDXS N/A
- Revenue Growth
- FMAO N/A
- CDXS N/A
- 52 Week Low
- FMAO $18.99
- CDXS $2.53
- 52 Week High
- FMAO $34.15
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- FMAO 39.11
- CDXS 59.97
- Support Level
- FMAO $31.70
- CDXS $5.42
- Resistance Level
- FMAO $33.02
- CDXS $6.01
- Average True Range (ATR)
- FMAO 1.03
- CDXS 0.39
- MACD
- FMAO -0.51
- CDXS -0.05
- Stochastic Oscillator
- FMAO 21.04
- CDXS 46.67
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company for Farmers & Merchants Bank of Central California. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.
About CDXS Codexis Inc.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.